Integrum AB (OSTO:INTEG B) Debt-to-Equity : 0.05 (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Integrum AB Debt-to-Equity?

Integrum AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was kr1.56 Mil. Integrum AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was kr5.25 Mil. Integrum AB's Total Stockholders Equity for the quarter that ended in Jan. 2024 was kr140.40 Mil. Integrum AB's debt to equity for the quarter that ended in Jan. 2024 was 0.05.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Integrum AB's Debt-to-Equity or its related term are showing as below:

OSTO:INTEG B' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.06 Max: 4.69
Current: 0.05

During the past 9 years, the highest Debt-to-Equity Ratio of Integrum AB was 4.69. The lowest was 0.00. And the median was 0.06.

OSTO:INTEG B's Debt-to-Equity is ranked better than
80.34% of 702 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs OSTO:INTEG B: 0.05

Integrum AB Debt-to-Equity Historical Data

The historical data trend for Integrum AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrum AB Debt-to-Equity Chart

Integrum AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Debt-to-Equity

Get a 7-Day Free Trial

0.09

0.11

0.06

Integrum AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Debt-to-Equity	Get a 7-Day Free Trial															-	0.06	0.06	0.05	0.05

Competitive Comparison of Integrum AB's Debt-to-Equity

For the Medical Devices subindustry, Integrum AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integrum AB's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integrum AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Integrum AB's Debt-to-Equity falls into.

Integrum AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Integrum AB's Debt to Equity Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.491	+	6.424)	/	143.531
	=	0.06

Integrum AB's Debt to Equity Ratio for the quarter that ended in Jan. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.557	+	5.248)	/	140.402
	=	0.05

Integrum AB (OSTO:INTEG B) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Integrum AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Integrum AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrum AB (OSTO:INTEG B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integrum AB (OSTO:INTEG B) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

6Y1:Germany

Address

Krokslatts Fabriker 50, Molndal, SWE, SE-431 37

Website

http://www.integrum.se

Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.

Integrum AB (OSTO:INTEG B) Headlines

No Headlines